Barclay Pearce Capital
- Jun 23, 2026
- 1 min read
ABSI - Healthcare Sector Review: Countercyclical or Carnage?
While investor attention remains firmly focused on technology, artificial intelligence and mining, the healthcare sector has largely fallen off the public radar. The S&P/ASX 200 Health Care Index (ASX: XHJ) has experienced a prolonged period of underperformance, with the recent decline proving particularly severe relative to other sector indices.
The magnitude of the sell-off has erased years of cumulative gains and pushed valuation and technical measures toward extreme levels. Although the precise drivers remain open to debate (deteriorating earnings expectations, constituent-specific challenges, structural headwinds, or investor sentiment), the extent of the underperformance warrants closer scrutiny.
Gain Access to the Full Desk Note
Investor Highlights
-
The Australian healthcare sector is approaching valuation and sentiment levels rarely seen over the past two decades.
-
A growing divergence between market pricing and underlying expectations has created one of the most interesting setups in recent years.
- Recent sector performance has diverged significantly from both historical trends and comparable global healthcare indices.
Share Link